Trial intelligence / Profile preview

Holiday: Fluconazole in Refractory Crohn's Disease

NCT02765256Phase 2Completed

Sponsor
University of Pennsylvania
Start
Aug 2016
Primary completion
Dec 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fluconazole in Crohn's disease, sponsored by University of Pennsylvania. Started Aug 2016; status: completed.

02

Drugs

fluconazole
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT02765256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02765256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call